RecruitingNCT07507877
Infraclavicular Axillary Vein Collapsibility Index as a Predictor of Fluid Responsiveness
Studying Antisynthetase syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Ain Shams University
- Intervention
- Infraclavicular axillary vein collapsibility index(other)
- Enrollment
- 40 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2026 – 2026
Study locations (1)
- Ain-Shams University Hospitals, Cairo, Egypt
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07507877 on ClinicalTrials.govOther trials for Antisynthetase syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07391605Descartes-08 in Autoantibody MyositisCartesian Therapeutics
- RECRUITINGNANCT07119255Effectiveness of PRP Pharmacopuncture for Chronic Neck Pain in Cervical Myofascial Syndrome of the Upper TrapeziusIndonesia University
- RECRUITINGEARLY PHASE1NCT06613490An Exploratory Clinical Study of CD19 CAR NK Cells for the Treatment of Refractory Antisynthetase Antibody Syndrome and Rheumatoid ArthritisThe First Affiliated Hospital with Nanjing Medical University
- RECRUITINGNANCT05726825Efficacy of Add-on Plasma Exchange As an Adjunctive Strategy Against Septic ShockHannover Medical School
- RECRUITINGNCT07126106Prospective Validation of GRADY: A Machine Learning Model for Early Sepsis and Bacteremia Detection in ICU PatientsSisli Hamidiye Etfal Training and Research Hospital
- RECRUITINGNCT07089524A Comparative Study Between Neutrophil/Lymphocyte Ratio and Lactate/Albumin Ratio as Predictive Inflammatory Markers for SepsisAin Shams University
- RECRUITINGNCT05984394Evaluation of Antigen-specific T Cells in Patients With Antisynthetase Syndrome and Interstitial Lung DiseaseCentral Hospital, Nancy, France
- RECRUITINGPHASE1NCT05986240Danvatirsen Monotherapy Followed by Combination With Venetoclax in Relapsed/Refractory MDS & AMLMontefiore Medical Center